SYMBYX PDCare Instruction Manual page 3

Description ............................................................................................................................................. 14
6.1
Expected life before service required ......................................................................................... 14
6.1.1
Medical purpose/intended use ............................................................................................................ 14
6.2
Patient ..................................................................................................................................................... 14
6.3
Operator ................................................................................................................................................. 14
6.4
Application ............................................................................................................................................. 14
6.5
Environment ........................................................................................................................................... 14
6.6
Home healthcare environment .................................................................................................... 15
6.6.1
Frequency of device use ...................................................................................................................... 15
6.7
Treatment/application time per patient .............................................................................................. 16
6.8
Treatment interval ................................................................................................................................. 16
6.9
Number of treatments per patient/sessions per patient .............................................................. 16
6.10
Treatment session interval .............................................................................................................. 17
6.11
Contraindications .............................................................................................................................. 17
6.12
Side effects ........................................................................................................................................ 17
6.13
Patient potential reaction ................................................................................................................. 17
6.14
Patient population ............................................................................................................................. 18
6.15
3